Endoscopic hemostasis system cleared by FDA for nonvariceal upper GI bleeding

October 1, 2022

The FDA granted clearance to Medtronic’s endoscopic hemostasis system, Nexpowder, intended to improve visibility and management of upper gastrointestinal bleeding not linked to varices, according to a company press release.“We are very excited to bring the innovative Nexpowder system to gastroenterologists,” Gio Di Napoli, president of gastrointestinal business at Medtronic, said in the release. “We considered the potential impact on physicians and patients alike by meeting a clear need to reduce mortality from upper GI bleeding, a condition that causes death for oneRead More

Categories: News

Related Articles

FDA approves Konvomep for benign gastric ulcers, risk reduction for upper GI bleeding

The FDA has approved an oral suspension omeprazole and sodium bicarbonate for the treatment of active benign gastric ulcer and to reduce risk for upper…

September 17, 2022

FDA grants de novo clearance for endoscopic sleeve gastroplasty, bariatric revision devices

The FDA has granted de novo authorization for Apollo Endosurgery to market its Apollo ESG and Apollo REVISE endoscopic systems for the treatment of patients…

FDA grants 510(k) clearance to AI-assisted polyp detection device

The FDA granted 510(k) clearance to Iterative Scopes, in association with Provation, for its computer-aided polyp detection device for adults undergoing colorectal cancer screening, according…

September 28, 2022

Let’s Talk About Physician Burnout

Physician Burnout has become a serious topic of discussion in the healthcare field lately. With such a large array of factors affecting the well-being…

Justin Bouck June 5, 2018

SonoScape video endoscopy system receives FDA 510(k) clearance

SonoScape Medical Corp. announced that the FDA has approved its video endoscopy system HD-550 for gastrointestinal diagnosis.According to a company press release, the HD-550 endoscopy…